Mike Matson


Needham Maintains Buy on Amedica Corporation Following 2Q:15 Results; Sees 88% Upside for the Stock

In a research report released today, Needham analyst Mike Matson reiterated a Buy rating on shares of Amedica Corporation (NASDAQ:AMDA) with a $1.00 price target, which represents …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts